Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

NCT01717170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Intermediate Uveitis
Posterior Uveitis
Pan-uveitis

Interventions

DRUG: Tocilizumab

Sponsor

University of Nebraska